GL1X · GenesisL1 explorer

MolNFT v1 · #185681 · protein

JAK2 in complex with 4-(2-{[5-(DIMETHYLAMINO)PENTYL]AMINO}-8-{[(2S)-1- hydroxypropan-2-YL]AMINO}QUINAZOLIN-6-yl)-5-ethyl-2-fluorophenol

7Q7W · Tyrosine-protein kinase JAK2: “JAK2 in complex with 4-(2-{[5-(DIMETHYLAMINO)PENTYL]AMINO}-8-{[(2S)-1…”. X-ray diffraction, 1 ligand (9HR), 3 pockets (best druggability 0.71). MolNFT v1 #185681 on GenesisL1: 3D structure, binding…

PDB
7Q7W
Type
protein
Length
292 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
9HR
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein29246% helix, 19% strandO60674

Ligands and binding sites

  • 9HR · 4-[2-[5-(dimethylamino)pentylamino]-8-[[(2~{S})-1-oxidanylpropan-2-yl]amino]quinazolin-6-yl]-5-ethyl-2-fluoranyl-phenol · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12710.710.86289HR
21550.510.7929empty
3760.320.7422empty

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 7Q7W · JAK2 in complex with 4-(2-{[5-(dimethylamino)pentyl]amino}-8-{[(2S)-1-hydroxypropan-2-yl]a… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.